Cite
HARVARD Citation
Ferris, L. et al. (2020). Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study. Journal of dermatological treatment. pp. 152-159. [Online].